Efficacy of Add-On Deep Transcranial Magnetic Stimulation in Comorbid Alcohol Dependence and Dysthymic Disorder
Authors:
- Georgios D. KotzalidisGeorgios D. Kotzalidis
- Daniele SerataDSDaniele Serata
- Antonio Del CasaleAntonio Del Casale
- Francesco S. BersaniFBFrancesco S. Bersani
- Andrea SolfanelliASAndrea Solfanelli
- Paola ScatenaPSPaola Scatena
- Ruggero N. RaccahRRRuggero N. Raccah
- Roberto BrugnoliRBRoberto Brugnoli
- Vittorio DigiacomantonioVDVittorio Digiacomantonio
- Paolo CarbonettiPCPaolo Carbonetti
- Claudio FensoreCFClaudio Fensore
- 7 February 2013
- journal article
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 15 (1)
Abstract
Craving for alcohol is associated with abnormal activation in the dorsolateral prefrontal cortex. Deep transcranial magnetic stimulation (dTMS) has shown promise in the treatment of depression. There are few treatment options for treatment-resistant dysthymic disorder comorbid with alcohol use disorder. To investigate the possible anticraving efficacy of bilateral dorsolateral prefrontal cortex high-frequency dTMS in 3 patients with comorbid long-term DSM-IV-TR dysthymic disorder and alcohol use disorder. Three patients with alcohol use disorder with dysthymic disorder in their detoxification phase (abstaining for > 1 month) underwent twenty 20-minute sessions of 20 Hz dTMS over the dorsolateral prefrontal cortex over 28 days between 2011 and 2012. Alcohol craving was rated with the Obsessive Compulsive Drinking Scale and depressive symptoms with the Hamilton Depression Rating Scale. All 3 patients responded unsatisfactorily to initial intravenous antidepressant and antianxiety combinations but responded after 10 dTMS sessions, improving on both anxiety-depressive symptoms and craving. This improvement enabled us to reduce antidepressant dosages after dTMS cycle completion. High-frequency bilateral dorsolateral prefrontal cortex dTMS with left prevalence was found to produce significant anticraving effects in alcohol use disorder comorbid with dysthymic disorder. The potential of dTMS for reducing craving in patients with substance use disorder deserves to be further investigated.Keywords
This publication has 38 references indexed in Scilit:
- Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use DisordersThe Journal of Clinical Psychiatry, 2011
- H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility studyThe World Journal of Biological Psychiatry, 2010
- Deep TMS in a resistant major depressive disorder: a brief reportDepression and Anxiety, 2010
- Brain stimulation in the study and treatment of addictionNeuroscience & Biobehavioral Reviews, 2010
- Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham‐controlled studyAddiction, 2009
- Transcranial Magnetotherapy in the Complex Treatment of Affective Disorders in Patients with AlcoholismNeuroscience and Behavioral Physiology, 2009
- Alcohol use and adherence to prescribed therapy among under-served Latino and African-American patients using emergency department services.2005
- Transcranial magnetic stimulation in neurologyThe Lancet Neurology, 2003
- The Health and Productivity Cost Burden of the “Top 10” Physical and Mental Health Conditions Affecting Six Large U.S. Employers in 1999Journal of Occupational and Environmental Medicine, 2003
- Theories of drug craving, ancient and modernAddiction, 2001